SMARCD3 and TCN1 were identified as key biomarkers associated with immune cell and metabolic reprogramming in ARDS, while RPL14 was identified as a candidate biomarker through computational approaches, offering valuable insights for understanding the pathogenesis of the disease. This evidence concerns the gene SMARCD3 and acute respiratory distress syndrome.